Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms/Experiment 1/Signature 2
From BugSigDB
Source: FIG 3 (A)
Description: Linear discriminant analysis effect size (LEfSe) analysis of microbial abundance between breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms. (A) Taxa with a significant difference in both groups were detected by LEfSe analysis with a linear discriminant analysis (LDA)
Abundance in Group 1: decreased abundance in Vulvovaginal symptoms
| NCBI | Quality Control | Links |
|---|---|---|
| Parvimonas micra |
Revision editor(s): Rahila
